Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity.

PubWeight™: 2.26‹?› | Rank: Top 2%

🔗 View Article (PMC 44808)

Published in Proc Natl Acad Sci U S A on September 27, 1994

Authors

G Harth1, D L Clemens, M A Horwitz

Author Affiliations

1: Department of Medicine, School of Medicine, University of California, Los Angeles 90024.

Articles citing this

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1995) 4.76

Non-classical protein secretion in bacteria. BMC Microbiol (2005) 3.17

Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun (1996) 2.43

Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun (1997) 2.37

Mycobacterium and the coat of many lipids. J Cell Biol (2002) 1.80

Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect Immun (2003) 1.76

An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med (1999) 1.75

High extracellular levels of Mycobacterium tuberculosis glutamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism. Infect Immun (2001) 1.73

Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc Natl Acad Sci U S A (2000) 1.65

glnE is an essential gene in Mycobacterium tuberculosis. J Bacteriol (2000) 1.59

Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun (2005) 1.49

Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv. BMC Microbiol (2010) 1.47

Release of lipopolysaccharide from intracellular compartments containing Salmonella typhimurium to vesicles of the host epithelial cell. Infect Immun (1997) 1.43

Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol (1995) 1.43

High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect Immun (1997) 1.42

Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis. J Bacteriol (2000) 1.38

Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun (1998) 1.38

Subcellular localization of the Iitracellular survival-enhancing Eis protein of Mycobacterium tuberculosis. Infect Immun (2001) 1.29

Identification of genes encoding exported Mycobacterium tuberculosis proteins using a Tn552'phoA in vitro transposition system. J Bacteriol (2000) 1.26

Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach. Infect Immun (2000) 1.18

Evaluation of Mycobacterium tuberculosis genes involved in resistance to killing by human macrophages. Infect Immun (2000) 1.16

Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect Immun (2003) 1.14

Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases. J Bacteriol (2000) 1.11

Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo. Infect Immun (2003) 1.09

Role of protein kinase G in growth and glutamine metabolism of Mycobacterium bovis BCG. J Bacteriol (2005) 1.08

Nitrogen control in Mycobacterium smegmatis: nitrogen-dependent expression of ammonium transport and assimilation proteins depends on the OmpR-type regulator GlnR. J Bacteriol (2008) 1.07

Functional analysis of GlnE, an essential adenylyl transferase in Mycobacterium tuberculosis. J Bacteriol (2008) 1.06

Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis. Clin Exp Immunol (2001) 1.02

Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One (2011) 1.02

Structure of Mycobacterium tuberculosis glutamine synthetase in complex with a transition-state mimic provides functional insights. Proc Natl Acad Sci U S A (2005) 0.97

Glutamate dehydrogenase and glutamine synthetase are regulated in response to nitrogen availability in Myocbacterium smegmatis. BMC Microbiol (2010) 0.90

Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2007) 0.90

Evaluation of signal peptide prediction algorithms for identification of mycobacterial signal peptides using sequence data from proteomic methods. Microbiology (2009) 0.89

The role of GlnD in ammonia assimilation in Mycobacterium tuberculosis. Tuberculosis (Edinb) (2007) 0.88

Heterogeneity of RNA polymerase gene (rpoB) sequences of Mycobacterium gordonae clinical isolates identified with a DNA probe kit and by conventional methods. J Clin Microbiol (2003) 0.88

Mutation and virulence assessment of chromosomal genes of Rhodococcus equi 103. Can J Vet Res (2007) 0.84

Part I: characterization of the extracellular proteome of the extreme thermophile Caldicellulosiruptor saccharolyticus by GeLC-MS2. Anal Bioanal Chem (2010) 0.83

Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors. J Med Chem (2012) 0.79

Adherence and invasive properties of Corynebacterium diphtheriae strains correlates with the predicted membrane-associated and secreted proteome. BMC Genomics (2015) 0.77

Computational and experimental analysis of the secretome of Methylococcus capsulatus (Bath). PLoS One (2014) 0.77

Syntheses of new tuberculosis inhibitors promoted by microwave irradiation. Ups J Med Sci (2014) 0.75

Spatially distinct and metabolically active membrane domain in mycobacteria. Proc Natl Acad Sci U S A (2016) 0.75

Poly-L-glutamate/glutamine synthesis in the cell wall of Mycobacterium bovis is regulated in response to nitrogen availability. BMC Microbiol (2013) 0.75

Articles cited by this

Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81

Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med (1971) 11.44

The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle (1991) 7.70

Regulation of glutamine synthetase. I. Purification and properties of glutamine synthetase from Escherichia coli. Arch Biochem Biophys (1966) 7.31

Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli. Biochemistry (1968) 6.68

Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol (1990) 5.39

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun (1992) 3.85

Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect Immun (1991) 3.62

Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature (1980) 2.89

Novel subunit-subunit interactions in the structure of glutamine synthetase. Nature (1986) 2.87

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods (1986) 2.50

Bacillus subtilis glutamine synthetase. Purification and physical characterization. J Biol Chem (1970) 2.10

Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J Bacteriol (1990) 2.10

Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase. Biochemistry (1969) 1.82

Effects of specific divalent cations on some physical and chemical properties of glutamine synthetase from Escherichia coli. Taut and relaxed enzyme forms. Biochemistry (1968) 1.52

Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomes. Infect Immun (1993) 1.35

The major iron-containing protein of Legionella pneumophila is an aconitase homologous with the human iron-responsive element-binding protein. J Bacteriol (1993) 1.18

Limited proteolysis of glutamine synthetase is inhibited by glutamate and by feedback inhibitors. J Biol Chem (1979) 1.12

Fluorogenic reaction and specific microdetermination of ammonia. J Biochem (1981) 1.11

Metal ion requirement by glutamine synthetase of Escherichia coli in catalysis of gamma-glutamyl transfer. Arch Biochem Biophys (1975) 1.02

IN VITRO TESTS WITH 4,4'-DIISOAMYLOXYTHIOCARBANILIDE. Am Rev Respir Dis (1964) 0.99

Physical and chemical characterization of glutamine synthetase purified from Mycobacterium phlei. J Biochem (1989) 0.85

Articles by these authors

Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest (1980) 12.41

The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med (1983) 8.82

Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes. J Exp Med (1983) 7.65

Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med (1995) 6.62

Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest (1980) 6.61

Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol (1990) 5.39

Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J Cell Biol (1984) 4.88

Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria. J Exp Med (1981) 4.08

Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell (1984) 4.00

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun (1992) 3.85

Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin. J Clin Invest (1983) 3.79

Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med (1987) 3.78

Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication. J Exp Med (1981) 3.73

Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J Clin Invest (1984) 3.59

The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med (1982) 3.52

Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest (1989) 3.36

Identification of a Legionella pneumophila locus required for intracellular multiplication in human macrophages. Proc Natl Acad Sci U S A (1992) 3.32

Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med (1981) 3.27

Phagocytosis of microorganisms. Rev Infect Dis (1982) 2.68

Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. J Immunol (1986) 2.62

Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. J Clin Invest (1995) 2.43

Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun (1996) 2.43

The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med (1996) 2.40

The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med (1996) 2.37

Isolation and characterization of the cytoplasmic and outer membranes of the Legionnaires' disease bacterium (Legionella pneumophila). J Exp Med (1985) 2.37

Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med (1996) 2.35

Cell-mediated immunity in Legionnaires' disease. J Clin Invest (1983) 2.30

Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol (1991) 2.21

Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins. Proc Natl Acad Sci U S A (1995) 2.17

Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J Exp Med (1989) 1.91

Purification of Legionella pneumophila major outer membrane protein and demonstration that it is a porin. J Bacteriol (1985) 1.91

IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol (1988) 1.87

Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J Exp Med (1990) 1.79

Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J Clin Invest (1993) 1.78

An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med (1999) 1.75

Defective production of monocyte-activating cytokines in lepromatous leprosy. J Exp Med (1984) 1.74

High extracellular levels of Mycobacterium tuberculosis glutamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism. Infect Immun (2001) 1.73

Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect Immun (2000) 1.71

The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium. J Immunol (1990) 1.70

Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest (1991) 1.68

Membrane sorting during phagocytosis: selective exclusion of major histocompatibility complex molecules but not complement receptor CR3 during conventional and coiling phagocytosis. J Exp Med (1992) 1.67

Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest (1990) 1.66

Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens. J Exp Med (1987) 1.66

Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc Natl Acad Sci U S A (2000) 1.65

Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined two-dimensional gel electrophoresis and mass spectrometry. Infect Immun (1999) 1.59

Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol (1995) 1.43

High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect Immun (1997) 1.42

Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease. J Clin Invest (1993) 1.41

Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila. J Clin Invest (1991) 1.41

An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease. J Clin Invest (1990) 1.41

An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol (2001) 1.40

Outbreaks of waterborne disease in the United States, 1974. J Infect Dis (1976) 1.38

Expression and efficient export of enzymatically active Mycobacterium tuberculosis glutamine synthetase in Mycobacterium smegmatis and evidence that the information for export is contained within the protein. J Biol Chem (1997) 1.36

Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomes. Infect Immun (1993) 1.35

Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria. J Biol Chem (1999) 1.33

Mycobacterium tuberculosis and Legionella pneumophila phagosomes exhibit arrested maturation despite acquisition of Rab7. Infect Immun (2000) 1.31

Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J Exp Med (1991) 1.27

Identification of iron-regulated proteins of Mycobacterium tuberculosis and cloning of tandem genes encoding a low iron-induced protein and a metal transporting ATPase with similarities to two-component metal transport systems. Microb Pathog (1998) 1.22

A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect Immun (1994) 1.21

Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella. J Immunol (1991) 1.21

The major iron-containing protein of Legionella pneumophila is an aconitase homologous with the human iron-responsive element-binding protein. J Bacteriol (1993) 1.18

Food-borne botulism in the United States, 1970-1975. J Infect Dis (1977) 1.10

T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. Infect Immun (1999) 1.08

A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge. J Clin Invest (1989) 1.07

Characterization of exochelins of Mycobacterium avium: evidence for saturated and unsaturated and for acid and ester forms. J Bacteriol (1996) 1.03

Renin, angiotensins, and angiotensin-converting enzyme in neuroblastoma cells: evidence for intracellular formation of angiotensins. Proc Natl Acad Sci U S A (1981) 1.03

Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. J Immunol (1986) 1.01

A large outbreak of foodborne salmonellosis on the Navajo Nation Indian Reservation, epidemiology and secondary transmission. Am J Public Health (1977) 1.00

Characterization of exochelins of the Mycobacterium bovis type strain and BCG substrains. Infect Immun (1999) 0.99

Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient. A method for selectively removing interfering substances from clinical specimens. Am J Clin Pathol (1976) 0.98

Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila. J Clin Invest (1991) 0.95

Foodborne disease outbreaks of chemical etiology in the United States, 1970-1974. Am J Epidemiol (1977) 0.94

Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury. Proc Natl Acad Sci U S A (1998) 0.90

Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonads. Exp Parasitol (2001) 0.89

An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro. J Biol Chem (2000) 0.89

The roles of the Fc and C3 receptors in the phagocytosis and killing of bacteria by human phagocytes. J Reticuloendothel Soc (1980) 0.88

Renin in rat and mouse brain: immunohistochemical identification and localization. Clin Sci (Lond) (1980) 0.87

Legionella pneumophila invasion of mononuclear phagocytes. Curr Top Microbiol Immunol (1996) 0.87

Brain renin. Clin Exp Hypertens A (1982) 0.85

A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation (2001) 0.85

Aberrantly low transferrin receptor expression on human monocytes is associated with nonpermissiveness for Legionella pneumophila growth. J Infect Dis (2000) 0.84

Specific diagnosis of foodborne disease. Gastroenterology (1977) 0.84

Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clin Biochem (2001) 0.84

Symbiotic interactions between Legionella pneumophila and human leukocytes. Int Rev Cytol Suppl (1983) 0.83

Generation of angiotensins in cultured pheochromocytoma cells. Neurosci Lett (1984) 0.83

Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells. Breast Cancer Res Treat (2001) 0.83

Type A botulism from commercially canned beef stew. South Med J (1977) 0.83

An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation (2001) 0.82

Use of cultured cells in assessing ethanol toxicity and ethanol-related metabolism. Alcohol Clin Exp Res (2001) 0.81

Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3,3',5-triiodothyronine as the substrate. J Endocrinol (2001) 0.81

Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1)*. Biochem Pharmacol (2000) 0.81

Nursery outbreak of peritonitis with pneumoperitoneum probably caused by thermometer-induced rectal perforation. Am J Epidemiol (1976) 0.80

Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem Biol Interact (1998) 0.80

Characterization of recombinant human liver thermolabile phenol sulfotransferase with minoxidil as the substrate. Biochem Biophys Res Commun (1995) 0.80

Do I dare? Using role-play as a teaching strategy. J Psychosoc Nurs Ment Health Serv (1998) 0.78

Generation of angiotensinogen by cultured neuroblastoma and glioma cells. Brain Res (1986) 0.78

Interferon-gamma and antibiotics fail to act synergistically to kill Legionella pneumophila in human monocytes. J Interferon Res (1988) 0.78

Long-term ethanol feeding selectively impairs the attachment of rat perivenous hepatocytes to extracellular matrix substrates. Gastroenterology (1994) 0.77

Phagosome-lysosome fusion. Biochem Soc Trans (1986) 0.77